Product introduction
Lenvakast 4mg Capsule is used to treat certain types of cancers like differentiated thyroid cancer, liver cancer, kidney cancer, and endometrial cancer. It works by blocking specific proteins that promote cancer cell growth and spread, and reducing tumor size in affected individuals.
Lenvakast 4mg Capsule can be taken with or without food, but try to have it at the same time every day to get the most benefits. Your doctor will determine the right dose and how often you should take it. This will depend on what you are being treated for. The dosage may change over time. You should take it exactly as your doctor has advised. Taking it the wrong way or taking too much can cause very serious side effects.
Common side effects of this medicine include high blood pressure, bleeding, and diarrhea. It might also cause severe headaches and loss of appetite. If any of these side effects persist or worsen, consult your doctor. They may be able to suggest ways to manage the side effects.
Before taking Lenvakast 4mg Capsule, tell your doctor if you have heart disease, liver, or kidney problems, or are taking any medicines to treat infections. Many other medicines can affect or be affected by this medicine, so let your doctor know about all the medicines you are taking. Pregnant and breastfeeding women should consult their doctors before starting this medicine, as it may cause harm to the developing baby.
Uses of Lenvakast Capsule
- Differentiated Thyroid cancer
- Treatment of Kidney cancer
- Liver cancer
- Treatment of Endometrial cancer
Benefits of Lenvakast Capsule
In Differentiated Thyroid cancer
Side effects of Lenvakast Capsule
Common side effects of Lenvakast
- High blood pressure
- Diarrhea
- Increased bleeding tendency
How to use Lenvakast Capsule
How Lenvakast Capsule works
Safety advice

Alcohol

Pregnancy

Breast feeding

Driving

Kidney

Liver
What if you forget to take Lenvakast Capsule?
Quick tips
- Take it with or without food, preferably at the same time each day.
- Use a reliable contraceptive method to prevent pregnancy while you are taking this medicine and for a month after you stop taking it.
- Monitor your blood pressure regularly while taking this medication. Inform your doctor if you notice symptoms of very high blood pressure, such as severe headache, confusion, problems with your eyesight, nausea, or vomiting.
- It may cause serious bleeding problems. Inform your doctor if you get headaches or stomach pain or if you notice blood in your urine or stools.
- Consult your doctor if you are pregnant, planning to conceive, or breastfeeding.
FAQs
How will I know if Lenvakast 4mg Capsule is working?
What are the most serious side effects of Lenvakast 4mg Capsule I should watch out for?
Can I stop taking Lenvakast 4mg Capsule if my symptoms have improved?
Who should avoid taking Lenvakast 4mg Capsule?
Will I need regular check-ups or tests while taking Lenvakast 4mg Capsule?
How long do I have to continue taking Lenvakast 4mg Capsule?
Does Lenvakast 4mg Capsule affect my fertility?
What other precautions should I take during Lenvakast 4mg Capsule treatment?
References:-
- Philippines Food and Drug Administration (FDA) – Drug Registration (Specific Product):
- https://verification.fda.gov.ph/drug_productsview.php?showdetail=®istration_number=DR-XY45688
- (Registration entry for Lenvima 4mg Capsule in the Philippines FDA portal, confirming local approval and generic name.)
- U.S. Food and Drug Administration (FDA) – Approval Summary (for HCC Indication):
- https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-lenvatinib-unresectable-hepatocellular-carcinoma
- (FDA approval summary based on the REFLECT trial for unresectable Hepatocellular Carcinoma (HCC).)
- NIH – PubMed Central (PMC) – Thyroid Cancer Efficacy (SELECT Trial):
- https://pmc.ncbi.nlm.nih.gov/articles/PMC6188100/
- (Review of Lenvatinib in Differentiated Thyroid Cancer and Advanced Renal Cell Carcinoma, highlighting the SELECT trial data.)
- ResearchGate – Comparative Efficacy in Liver Cancer (HCC):
- https://www.researchgate.net/publication/393233486_Enzalutamide_treatment_of_patients_with_advanced_prostate_cancer_across_the_disease_spectrum_plain_language_review
- (Research on survival outcomes with Lenvatinib in HCC compared to Sorafenib.)
- NIH – PubMed Central (PMC) – Real-World Safety Data:
- https://pmc.ncbi.nlm.nih.gov/articles/PMC9032633/
- (Real-world data study on Lenvatinib safety and efficacy, focusing on side effects like hypertension in advanced thyroid cancer.)


Reviews
There are no reviews yet.